American International Group, Inc. Uro Gen Pharma Ltd. Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.81 - $19.33 $1,974 - $2,764	143 Added 1.06%	13,664 $204,000
Q4 2023 Feb 13, 2024	BUY	$10.87 - $15.93 $40,827 - $59,833	3,756 Added 38.46%	13,521 $202,000
Q3 2023 Nov 13, 2023	BUY	$8.84 - $22.64 $3,076 - $7,878	348 Added 3.7%	9,765 $136,000
Q2 2023 Aug 04, 2023	BUY	$8.75 - $14.29 $82,398 - $134,568	9,417 New	9,417 $97,000
Q2 2022 Aug 12, 2022	SELL	$5.12 - $8.74 $49,587 - $84,646	-9,685 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.92 - $9.73 $4,037 - $6,635	-682 Reduced 6.58%	9,685 $84,000
Q4 2021 Feb 11, 2022	SELL	$9.03 - $19.13 $2,790 - $5,911	-309 Reduced 2.89%	10,367 $99,000
Q3 2021 Nov 12, 2021	SELL	$14.31 - $18.39 $3,634 - $4,671	-254 Reduced 2.32%	10,676 $180,000
Q2 2021 Aug 13, 2021	SELL	$15.2 - $20.94 $5,563 - $7,664	-366 Reduced 3.24%	10,930 $167,000
Q1 2021 May 07, 2021	BUY	$17.99 - $26.96 $521 - $781	29 Added 0.26%	11,296 $220,000
Q4 2020 Feb 12, 2021	SELL	$17.54 - $25.43 $5,682 - $8,239	-324 Reduced 2.8%	11,267 $203,000
Q3 2020 Nov 04, 2020	SELL	$18.81 - $26.42 $4,928 - $6,922	-262 Reduced 2.21%	11,591 $224,000
Q2 2020 Aug 12, 2020	BUY	$16.5 - $29.7 $12,573 - $22,631	762 Added 6.87%	11,853 $310,000
Q1 2020 May 04, 2020	SELL	$13.68 - $34.6 $8,782 - $22,213	-642 Reduced 5.47%	11,091 $198,000
Q4 2019 Feb 05, 2020	SELL	$21.11 - $34.86 $2,068 - $3,416	-98 Reduced 0.83%	11,733 $392,000
Q3 2019 Nov 08, 2019	SELL	$23.83 - $36.44 $1,954 - $2,988	-82 Reduced 0.69%	11,831 $282,000
Q2 2019 Aug 23, 2019	BUY	$32.75 - $40.35 $390,150 - $480,689	11,913 New	11,913 $428,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.